🔎 Trials Near Me

Početna › Epilepsija › Illinois

Kliničke studije za Epilepsija u državi Illinois

7 studija za Epilepsija traži sudionike na lokacijama u državi Illinois.

Gradovi u državi Illinois

Službeni tekst studije (engleski)

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

  • Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
1 Day – 6 Months · Oba spola · Ažurirano 2. lis 2026. · NCT05104983

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Re:Cognition Health-Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07594119

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  • Southern Illinois University School of Medicine, Springfield
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 10. kol 2026. · NCT05667142

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaOpažajna studija
Do 26 godina · Oba spola · Ažurirano 6. kol 2026. · NCT05374824

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

  • Praxis Research Site, Chicago
U tijeku regrutacijaFaza 3
1 Day – 18 Years · Oba spola · Ažurirano 3. kol 2026. · NCT07019922

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Rush University Medical Center, Chicago
  • University of Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 9. lip 2026. · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Southern Illinois University School of Medicine, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. svi 2026. · NCT05716100

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.